BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 15719008)

  • 21. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.
    Tedaldi EM; Baker RK; Moorman AC; Alzola CF; Furhrer J; McCabe RE; Wood KC; Holmberg SD;
    Clin Infect Dis; 2003 Feb; 36(3):363-7. PubMed ID: 12539079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus and human immunodeficiency virus: a dangerous dealing.
    Pellicano R; Fagoonee S; Repici A; Rizzetto M
    Panminerva Med; 2007 Jun; 49(2):79-82. PubMed ID: 17625484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunodeficiency virus and hepatitis C virus co-infection.
    Vlahakis SR
    J Med Liban; 2006; 54(2):106-10. PubMed ID: 17087002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anemia during treatment of hepatitis C in HIV-infected patients.
    Lo Re V; Kostman JR
    AIDS Read; 2004 Oct; 14(10):555-7, 562, 565-71. PubMed ID: 15510392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of chronic hepatitis B and C in HIV-coinfected patients.
    Soriano V; Barreiro P; Nuñez M
    J Antimicrob Chemother; 2006 May; 57(5):815-8. PubMed ID: 16556638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Coinfection with hepatitis C virus and HIV].
    Ruys TA; Reesink HW; Lange JM
    Ned Tijdschr Geneeskd; 2003 Oct; 147(42):2056-60. PubMed ID: 14606352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of viral kinetics under HCV therapy in HIV/HCV-coinfected patients.
    Ballesteros AL; Fuster D; Planas R; Clotet B; Tural C
    J Antimicrob Chemother; 2005 Jun; 55(6):824-7. PubMed ID: 15886264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV/HCV coinfection.
    Roehr B
    J Int Assoc Physicians AIDS Care; 1998 Jul; 4(7):30. PubMed ID: 11365639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial DNA depletion in HIV-infected patients is more pronounced with chronic hepatitis C and enhanced following treatment with pegylated interferon plus ribavirin.
    de Mendoza C; Sánchez-Conde M; Timmermans E; Buitelaar M; de Baar MP; Gonzalez-Lahoz J; Soriano V
    Antivir Ther; 2005; 10(4):557-61. PubMed ID: 16038482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment.
    Fleming CA; Craven DE; Thornton D; Tumilty S; Nunes D
    Clin Infect Dis; 2003 Jan; 36(1):97-100. PubMed ID: 12491208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of hepatitis C virus coinfection in HIV-infected persons.
    O'Leary JG; Chung RT
    AIDS Read; 2006 Jun; 16(6):313-6, 318-20. PubMed ID: 16795921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delivering therapy for hepatitis C virus infection to incarcerated HIV-seropositive patients.
    McGovern B; Fiore J; Wurcel A; Taglienti P; Bradley M; Galvin S; Libone G; Ramsey J; Molinaro-Gudas V; Drewniak S; Amick C; Andalkar A; Scheft H; Bica I
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S56-62. PubMed ID: 16265615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of liver biopsy in the evaluation of hepatitis C virus infection in HIV coinfection.
    Sterling RK
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S270-5. PubMed ID: 15768334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of HCV-related end-stage liver disease in HIV-coinfected patients.
    Merchante N; Jiménez-Saenz M; Pineda JA
    AIDS Rev; 2007; 9(3):131-9. PubMed ID: 17982938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HCV and HIV: a tale of two viruses.
    Sherman KE
    Rev Gastroenterol Disord; 2004; 4 Suppl 1():S48-54. PubMed ID: 15185718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges in the treatment of HIV and HCV coinfection.
    Streeck H; Rockstroh JK
    Expert Rev Clin Immunol; 2006 Sep; 2(5):811-22. PubMed ID: 20477635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.
    Mehta SH; Thomas DL; Torbenson M; Brinkley S; Mirel L; Chaisson RE; Moore RD; Sulkowski MS
    Hepatology; 2005 Jan; 41(1):123-31. PubMed ID: 15619237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C and human immunodeficiency virus infection.
    Thomas DL
    Hepatology; 2002 Nov; 36(5 Suppl 1):S201-9. PubMed ID: 12407595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus/human immunodeficiency virus coinfection: clinical management issues.
    Poles MA; Dieterich DT
    Clin Infect Dis; 2000 Jul; 31(1):154-61. PubMed ID: 10913414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of end-stage liver disease in HIV/hepatitis C virus co-infection.
    Spengler U
    Curr Opin HIV AIDS; 2011 Nov; 6(6):527-33. PubMed ID: 21918437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.